Palvella Therapeutics (PVLA) EBT Margin (2014 - 2024)
Palvella Therapeutics (PVLA) reported EBT Margin of 4784.91% for Q1 2024, down 400216.0% year-over-year from N/an in Q2 2023, and down 6517.18% on a QoQ basis from 72.31% in Q3 2023.
Palvella Therapeutics (PVLA) has 11 years of EBT Margin data on file, last reported at 4784.91% in Q1 2024.
- Quarterly EBT Margin fell 400216.0% year-over-year to 4784.91% in Q1 2024, while the trailing twelve-month figure through Sep 2024 was 0.62% (up 9401.0% YoY) and the FY2021 annual result came in at 163.7%, down 3729.0% from the prior year.
- EBT Margin declined to 4784.91% in Q1 2024 per PVLA's latest filing, from 72.31% in the prior quarter.
- Across five years, EBT Margin topped out at 12.73% in Q2 2023 and bottomed at 4784.91% in Q1 2024.
- The 5-year median for EBT Margin is 351.73% (2022), against an average of 896.08%.
- The widest annual swing landed in 2023, when EBT Margin jumped 455056 bps; it then sank 400216 bps in 2024.
- Tracing PVLA's EBT Margin over 5 years: stood at 660.79% in 2020, then jumped by 66 bps to 221.65% in 2021, then tumbled by 1986 bps to 4622.87% in 2022, then jumped by 98 bps to 72.31% in 2023, then plunged by 6517 bps to 4784.91% in 2024.
- Per Business Quant, the three latest PVLA EBT Margin figures stand at 4784.91% (Q1 2024), 72.31% (Q3 2023), and 12.73% (Q2 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -4,784.91% |
| Sep 30, 2023 | -72.31% |
| Jun 30, 2023 | 12.73% |
| Mar 31, 2023 | -782.75% |
| Sep 30, 2022 | -4,622.87% |
| Jun 30, 2022 | -351.73% |
| Mar 31, 2022 | -67.89% |
| Dec 31, 2021 | -221.65% |
| Sep 30, 2021 | -683.00% |
| Jun 30, 2021 | -659.76% |
| Mar 31, 2021 | -38.89% |
| Dec 31, 2020 | -660.79% |
| Sep 30, 2020 | -440.42% |
| Jun 30, 2020 | -40.25% |
| Mar 31, 2020 | -26.67% |
| Dec 31, 2019 | -25.23% |
| Sep 30, 2019 | -17.13% |
| Jun 30, 2019 | -220.52% |
| Mar 31, 2019 | -121.10% |
| Dec 31, 2018 | -1,974.33% |
| Sep 30, 2018 | -73.73% |
| Jun 30, 2018 | -3.00% |
| Mar 31, 2018 | -209.87% |
| Dec 31, 2017 | 42.06% |
| Sep 30, 2017 | -176.04% |
| Jun 30, 2017 | -500.32% |
| Mar 31, 2017 | -595.23% |
| Dec 31, 2016 | -234.61% |
| Sep 30, 2016 | -789.32% |
| Jun 30, 2016 | -548.37% |
| Mar 31, 2016 | -333.78% |
| Dec 31, 2015 | 646.92% |
| Sep 30, 2015 | -936.26% |
| Jun 30, 2015 | -2,202.89% |
| Mar 31, 2015 | -1,702.38% |
| Sep 30, 2014 | -10,799.78% |
| Jun 30, 2014 | -412.71% |